Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia
Not Applicable
Recruiting
- Conditions
- type 2 diabetes complicated with dyslipidemia
- Registration Number
- JPRN-UMIN000006537
- Lead Sponsor
- Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with hypersensitivity against ezetimibe and pravastatin, 2)Patients with severe renal dysfunction and severe hepatic dysfunction, 3)Pregnant women, women who may be pregnant, and breast-feeding women. 4)Patients with drug-induced and familial dyslipidemia, 5)Patients treated with insulin 6)Patients judged by the investigator/ sub investigator to be ineligible for some other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change and percent change in TC, LDL-C, HDL-C, TG, Remnant like particle cholesterol (RLP-C), small dense LDL and FFA. Change and percent change in HbA1c and insulin
- Secondary Outcome Measures
Name Time Method